Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Ulm University Hospital / Comprehensive Cancer Center Ulm, Thioredoxin reductase 1, Beckman Coulter, A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies and the tag heme.
Shares Xanthine oxidase (XDH), Nkarta, Stephen J. Forman, NK cell therapy and CAR-NK and the tag heme.
Shares Akifumi Takaori, Martin Bornhäuser, JW Pharmaceutical, Mission Bio and the tag heme.
Shares A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies, Ryvu Therapeutics, Cellectis, Shenzhen TargetRx and the tag heme.
Shares Unicar-Therapy, Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies, TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies, IMPDH1 and the tag heme.
Shares Allogeneic stem cell transplantation, Etoposide and the tag heme.
Shares TP53, Antibody-drug conjugate (ADC) and the tag heme.
Shares Allogeneic stem cell transplantation, Antibody-drug conjugate (ADC) and the tag heme.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.